| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |